KLAC
53
-3
OKE
78
3
CVX
46
8
CMCSA
48
-2
DOV
69
2
DOW
43
-3
LLY
53
6
ZION
69
-2
BXP
60
5
VRSN
58
2
BF.B
33
-4
MSI
73
3
DLTR
40
-2
PYPL
56
-4
GWW
76
2
AMG
57
2
EXPD
48
-5
GM
65
-7
HIG
75
4
CF
56
3
KLAC
53
-3
OKE
78
3
CVX
46
8
CMCSA
48
-2
DOV
69
2
DOW
43
-3
LLY
53
6
ZION
69
-2
BXP
60
5
VRSN
58
2
BF.B
33
-4
MSI
73
3
DLTR
40
-2
PYPL
56
-4
GWW
76
2
AMG
57
2
EXPD
48
-5
GM
65
-7
HIG
75
4
CF
56
3
Financhill
Back

First American Financial Vs. Sarepta Therapeutics Industry Stock Comparison

Buy
77

FAF
First American Financial

Last Price:
70.58
Seasonality Move:
4.87%
Sell
49

SRPT
Sarepta Therapeutics

Last Price:
136.77
Seasonality Move:
14.88%
Buy
77
First American Financial (FAF) is a Buy

Is First American Financial a Buy, Sell or Hold?

  • The current First American Financial [FAF] share price is $69.25. The Score for FAF is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • FAF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $130.50. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FAF Stock Price Chart

What is First American Financial's stock price today?

  • The First American Financial share price today is $69.25
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FAF is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $130.50
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

FAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.08 Buy
Relative Strength Index (14 RSI): 72.27 Buy
Chaikin Money Flow: 462850 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.82 - 66.62) Buy
Bollinger Bands (100): (59.48 - 66.3) Buy

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.3 Sell
Relative Strength Index (14 RSI): 64.59 Buy
Chaikin Money Flow: 3149400 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.02 - 128.88) Buy
Bollinger Bands (100): (119.18 - 142.3) Sell

FAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 67 Buy
20-day SMA: 64.96 Buy
50-day SMA: 65.02 Buy
200-day SMA: 59.52 Buy
8-day EMA: 67.32 Buy
20-day EMA: 65.83 Buy
50-day EMA: 64.69 Buy
200-day EMA: 61.08 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.07 Buy
20-day SMA: 117.27 Buy
50-day SMA: 121.92 Buy
200-day SMA: 129.99 Buy
8-day EMA: 116.28 Buy
20-day EMA: 117.14 Buy
50-day EMA: 121.91 Buy
200-day EMA: 125.98 Buy

First American Financial Earnings Growth & FAF Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $1.41 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.87 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.76 per share.

First American Financial Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):